APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contrast Agents for Magnetic Resonance Imaging (MRI)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchContrast Agents for Magnetic Resonance Imaging (MRI) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Contrast Agents for Magnetic Resonance Imaging (MRI) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Contrast Agents for Magnetic Resonance Imaging (MRI), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Contrast Agents for Magnetic Resonance Imaging (MRI), also provides the sales of main regions and countries. Of the upcoming market potential for Contrast Agents for Magnetic Resonance Imaging (MRI), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contrast Agents for Magnetic Resonance Imaging (MRI) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Contrast Agents for Magnetic Resonance Imaging (MRI) sales, projected growth trends, production technology, application and end-user industry.

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application

Radiology

Interventional Radiology

Interventional Cardiology

Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contrast Agents for Magnetic Resonance Imaging (MRI) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contrast Agents for Magnetic Resonance Imaging (MRI).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Contrast Agents for Magnetic Resonance Imaging (MRI) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contrast Agents for Magnetic Resonance Imaging (MRI) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microbubble Contrast Media Major Manufacturers Table 3. Gadolinium-based Contrast Media Major Manufacturers Table 4. Iodinated Contrast Media Major Manufacturers Table 5. Barium-based Contrast Media Major Manufacturers Table 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Radiology Major Manufacturers Table 8. Interventional Radiology Major Manufacturers Table 9. Interventional Cardiology Major Manufacturers Table 10. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends Table 11. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers Table 12. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges Table 13. Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints Table 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2021-2026) Table 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2027-2032) Table 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2026) & (k units) Table 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2027-2032) & (k units) Table 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2021-2026) Table 23. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2027-2032) Table 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2021-2026) Table 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers, Product Type & Application Table 32. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2026) Table 39. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2027-2032) Table 40. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 42. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 43. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2026) Table 44. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2027-2032) Table 45. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2026) & (US$/unit) Table 46. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2027-2032) & (US$/unit) Table 47. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2026) Table 51. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2027-2032) Table 52. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 54. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 55. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2026) Table 56. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2027-2032) Table 57. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2026) & (US$/unit) Table 58. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2027-2032) & (US$/unit) Table 59. Daiichi Sankyo (Japan) Company Information Table 60. Daiichi Sankyo (Japan) Business Overview Table 61. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 63. Daiichi Sankyo (Japan) Recent Development Table 64. Bayer HealthCare (Germany) Company Information Table 65. Bayer HealthCare (Germany) Business Overview Table 66. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 68. Bayer HealthCare (Germany) Recent Development Table 69. Unijules Life Sciences (India) Company Information Table 70. Unijules Life Sciences (India) Business Overview Table 71. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 73. Unijules Life Sciences (India) Recent Development Table 74. Taejoon Pharm (South Korea) Company Information Table 75. Taejoon Pharm (South Korea) Business Overview Table 76. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 78. Taejoon Pharm (South Korea) Recent Development Table 79. Spago Nanomedicine (Sweden) Company Information Table 80. Spago Nanomedicine (Sweden) Business Overview Table 81. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 83. Spago Nanomedicine (Sweden) Recent Development Table 84. Magnus Health (India) Company Information Table 85. Magnus Health (India) Business Overview Table 86. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 88. Magnus Health (India) Recent Development Table 89. Lantheus (US) Company Information Table 90. Lantheus (US) Business Overview Table 91. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 93. Lantheus (US) Recent Development Table 94. Jodas (India) Company Information Table 95. Jodas (India) Business Overview Table 96. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 98. Jodas (India) Recent Development Table 99. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 100. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 101. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 103. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 104. Guerbet (France) Company Information Table 105. Guerbet (France) Business Overview Table 106. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 108. Guerbet (France) Recent Development Table 109. GE Healthcare (US) Company Information Table 110. GE Healthcare (US) Business Overview Table 111. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 113. GE Healthcare (US) Recent Development Table 114. Bracco Imaging (Italy) Company Information Table 115. Bracco Imaging (Italy) Business Overview Table 116. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio Table 118. Bracco Imaging (Italy) Recent Development Table 119. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 122. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 123. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2021-2026) & (US$/unit) Table 124. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2027-2032) & (US$/unit) Table 125. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 128. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 129. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2021-2026) & (US$/unit) Table 130. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2027-2032) & (US$/unit) Table 131. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 135. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 136. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 137. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2021-2026) & (US$/unit) Table 138. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2027-2032) & (US$/unit) Table 139. United States Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 140. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 141. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 142. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 145. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 146. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2021-2026) & (US$/unit) Table 147. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2027-2032) & (US$/unit) Table 148. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 151. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 152. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2021-2026) & (US$/unit) Table 153. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2027-2032) & (US$/unit) Table 154. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 158. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 159. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 160. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2021-2026) & (US$/unit) Table 161. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2027-2032) & (US$/unit) Table 162. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 163. France Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 164. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 165. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 166. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 167. Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 169. Switzerland Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 170. Sweden Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 171. Poland Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 172. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 173. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 174. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 175. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 176. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2021-2026) & (US$/unit) Table 177. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2027-2032) & (US$/unit) Table 178. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 179. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 180. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 181. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 182. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2021-2026) & (US$/unit) Table 183. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2027-2032) & (US$/unit) Table 184. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 185. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 186. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 187. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 188. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2021-2026) & (US$/unit) Table 189. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2027-2032) & (US$/unit) Table 190. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 191. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 193. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 194. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2021-2026) & (US$/unit) Table 195. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2027-2032) & (US$/unit) Table 196. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 200. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 201. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 202. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2021-2026) & (US$/unit) Table 203. Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2027-2032) & (US$/unit) Table 204. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 205. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 206. India Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 207. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 208. Taiwan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 209. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 210. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2026) & (US$ Million) Table 211. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2027-2032) & (US$ Million) Table 212. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2026) & (k units) Table 213. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2027-2032) & (k units) Table 214. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2021-2026) & (US$/unit) Table 215. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Type (2027-2032) & (US$/unit) Table 216. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2026) & (US$ Million) Table 217. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2027-2032) & (US$ Million) Table 218. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2026) & (k units) Table 219. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2027-2032) & (k units) Table 220. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2021-2026) & (US$/unit) Table 221. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Application (2027-2032) & (US$/unit) Table 222. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 226. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021-2026) & (k units) Table 227. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2027-2032) & (k units) Table 228. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2021-2026) & (US$/unit) Table 229. SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Country (2027-2032) & (US$/unit) Table 230. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 231. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 232. Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 233. Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 234. Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 235. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 236. Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 237. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 238. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 239. Iran Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 240. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List Table 244. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Image Figure 2. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microbubble Contrast Media Image Figure 5. Gadolinium-based Contrast Media Image Figure 6. Iodinated Contrast Media Image Figure 7. Barium-based Contrast Media Image Figure 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Share 2021 VS 2025 VS 2032 Figure 10. Radiology Image Figure 11. Interventional Radiology Image Figure 12. Interventional Cardiology Image Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2021-2032) & (US$ Million) Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2021-2032) Figure 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (2021-2032) & (k units) Figure 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2021-2032) & (k units) Figure 22. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2021-2032) & (k units) Figure 23. China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2021-2032) & (k units) Figure 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2032) Figure 32. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2032) Figure 35. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2032) Figure 38. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2032) Figure 41. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Type (2021-2032) Figure 42. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Type (2021-2032) Figure 43. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Application (2021-2032) Figure 44. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Application (2021-2032) Figure 45. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country (2021-2032) Figure 46. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Country (2021-2032) Figure 47. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Type (2021-2032) Figure 48. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Type (2021-2032) Figure 49. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Application (202

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Radiology
  • Interventional Radiology
  • Interventional Cardiology
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Type
  3. 1.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microbubble Contrast Media
  5. 1.2.3 Gadolinium-based Contrast Media
  6. 1.2.4 Iodinated Contrast Media
  7. 1.2.5 Barium-based Contrast Media
  8. 1.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Application
  9. 1.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Radiology
  11. 1.3.3 Interventional Radiology
  12. 1.3.4 Interventional Cardiology
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Dynamics
  1. 2.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
  2. 2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Drivers
  3. 2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Opportunities and Challenges
  4. 2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region
  3. 3.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2021-2026)
  5. 3.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2027-2032)
  6. 3.2.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region
  9. 3.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021-2026)
  11. 3.4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2027-2032)
  12. 3.4.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers
  2. 4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers
  6. 4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers, Product Type & Application
  13. 4.7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market CR5 and HHI
  16. 4.8.2 2025 Contrast Agents for Magnetic Resonance Imaging (MRI) Tier 1, Tier 2, and Tier 3
5 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Type
  1. 5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type
  2. 5.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type
  6. 5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type
6 Contrast Agents for Magnetic Resonance Imaging (MRI) Market by Application
  1. 6.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application
  2. 6.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application
  6. 6.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application
7 Company Profiles
  1. 7.1 Daiichi Sankyo (Japan)
  2. 7.1.1 Daiichi Sankyo (Japan) Company Information
  3. 7.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 7.1.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  6. 7.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 7.2 Bayer HealthCare (Germany)
  8. 7.2.1 Bayer HealthCare (Germany) Company Information
  9. 7.2.2 Bayer HealthCare (Germany) Business Overview
  10. 7.2.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  12. 7.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 7.3 Unijules Life Sciences (India)
  14. 7.3.1 Unijules Life Sciences (India) Company Information
  15. 7.3.2 Unijules Life Sciences (India) Business Overview
  16. 7.3.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  18. 7.3.5 Unijules Life Sciences (India) Recent Developments
  19. 7.4 Taejoon Pharm (South Korea)
  20. 7.4.1 Taejoon Pharm (South Korea) Company Information
  21. 7.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 7.4.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  24. 7.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 7.5 Spago Nanomedicine (Sweden)
  26. 7.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 7.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 7.5.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  30. 7.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 7.6 Magnus Health (India)
  32. 7.6.1 Magnus Health (India) Company Information
  33. 7.6.2 Magnus Health (India) Business Overview
  34. 7.6.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  36. 7.6.5 Magnus Health (India) Recent Developments
  37. 7.7 Lantheus (US)
  38. 7.7.1 Lantheus (US) Company Information
  39. 7.7.2 Lantheus (US) Business Overview
  40. 7.7.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  42. 7.7.5 Lantheus (US) Recent Developments
  43. 7.8 Jodas (India)
  44. 7.8.1 Jodas (India) Company Information
  45. 7.8.2 Jodas (India) Business Overview
  46. 7.8.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  48. 7.8.5 Jodas (India) Recent Developments
  49. 7.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 7.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 7.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 7.9.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  54. 7.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 7.10 Guerbet (France)
  56. 7.10.1 Guerbet (France) Company Information
  57. 7.10.2 Guerbet (France) Business Overview
  58. 7.10.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  60. 7.10.5 Guerbet (France) Recent Developments
  61. 7.11 GE Healthcare (US)
  62. 7.11.1 GE Healthcare (US) Company Information
  63. 7.11.2 GE Healthcare (US) Business Overview
  64. 7.11.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  66. 7.11.5 GE Healthcare (US) Recent Developments
  67. 7.12 Bracco Imaging (Italy)
  68. 7.12.1 Bracco Imaging (Italy) Company Information
  69. 7.12.2 Bracco Imaging (Italy) Business Overview
  70. 7.12.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
  72. 7.12.5 Bracco Imaging (Italy) Recent Developments
8 North America
  1. 8.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
  2. 8.1.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  3. 8.1.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  4. 8.1.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2032)
  5. 8.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
  6. 8.2.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  7. 8.2.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  8. 8.2.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2032)
  9. 8.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
  10. 8.3.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
  2. 9.1.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  4. 9.1.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2032)
  5. 9.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
  6. 9.2.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  8. 9.2.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2032)
  9. 9.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
  10. 9.3.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
  2. 10.1.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  3. 10.1.2 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  4. 10.1.3 China Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2032)
  5. 10.2 China Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
  6. 10.2.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  7. 10.2.2 China Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  8. 10.2.3 China Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
  2. 11.1.1 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  4. 11.1.3 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2032)
  5. 11.2 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
  6. 11.2.1 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  8. 11.2.3 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2032)
  9. 11.3 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
  10. 11.3.1 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
  2. 12.1.1 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2021-2032)
  5. 12.2 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
  6. 12.2.1 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2021-2032)
  9. 12.3 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
  10. 12.3.1 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain Analysis
  2. 13.1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process
  6. 13.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
  9. 13.2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst